SAR131675 Racemate is primarily used in research settings as a potent and selective antagonist of the chemokine receptor CXCR7. It plays a key role in studies related to cancer biology, particularly in understanding tumor growth, metastasis, and angiogenesis, as CXCR7 is often overexpressed in various tumor types. Researchers use SAR131675 Racemate to modulate CXCR7 signaling pathways, helping to dissect its function in both tumor cells and the tumor microenvironment. It is also applied in cardiovascular and inflammatory disease research due to the receptor's involvement in cell migration and survival. Its use remains confined to preclinical investigations, supporting drug discovery and mechanistic studies.